ATE220687T1 - Die erzeugung einer immunantwort gegen erwünschte determinanten - Google Patents

Die erzeugung einer immunantwort gegen erwünschte determinanten

Info

Publication number: ATE220687T1
Authority: AT; Austria
Prior art keywords: immune response; generation; response against; against desired; determinants
Prior art date: 1996-01-24

Application number

AT97902074T

Other languages

English (en)

Inventor

Jeffery L Alexander

Shawn Defrees

Alessandro Sette

Original Assignee

Epimmune Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-24

Filing date

1997-01-23

Publication date

2002-08-15

1997-01-23 Application filed by Epimmune Inc filed Critical Epimmune Inc

2002-08-15 Application granted granted Critical

2002-08-15 Publication of ATE220687T1 publication Critical patent/ATE220687T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Virology (AREA)
Mycology (AREA)
Microbiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Plant Substances (AREA)
Control Of High-Frequency Heating Circuits (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97902074T 1996-01-24 1997-01-23 Die erzeugung einer immunantwort gegen erwünschte determinanten ATE220687T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1051096P	1996-01-24	1996-01-24
PCT/US1997/001041 WO1997026784A1 (en)	1996-01-24	1997-01-23	Induction of immune response against desired determinants

Publications (1)

Publication Number	Publication Date
ATE220687T1 true ATE220687T1 (de)	2002-08-15

Family

ID=21746084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97902074T ATE220687T1 (de)	1996-01-24	1997-01-23	Die erzeugung einer immunantwort gegen erwünschte determinanten

Country Status (12)

Country	Link
EP (1)	EP0876398B1 (de)
JP (1)	JP4063879B2 (de)
CN (1)	CN1214051A (de)
AT (1)	ATE220687T1 (de)
AU (1)	AU1582797A (de)
BR (1)	BR9710404A (de)
CA (1)	CA2242878C (de)
DE (1)	DE69714011T2 (de)
DK (1)	DK0876398T3 (de)
ES (1)	ES2177927T3 (de)
PT (1)	PT876398E (de)
WO (1)	WO1997026784A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6528061B1 (en) *	1997-09-04	2003-03-04	Pasteur Institut	Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (de)	2002-12-10	2008-05-07	Idm Pharma, Inc.	HLA-A1, -A2, -A3, -A24, -B7 and -B44 bindende Peptide die Tumorassoziiert-Antigen Epitopen enthalten, und Zusammensetzungen davon
MXPA05006113A (es) *	2002-12-11	2005-09-30	Pharmexa As	Epitopos sencillos objetivo.
PT1620456E (pt)	2003-04-18	2014-04-15	Biotech Synergy Inc	Péptidos antigénicos hla-a2 associados a tumor e suas composições
ES2310072B1 (es)	2005-12-23	2009-11-16	Proyecto De Biomedicina Cima, S.L.	Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
US20110165067A1 (en) *	2007-08-17	2011-07-07	University Of Maryland Office Of Technology Commercialization	Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
EP2391635B1 (de) *	2009-01-28	2017-04-26	Epimmune Inc.	Pan-dr-bindende polypeptide und verwendungen davon
WO2012123269A1 (en)	2011-03-11	2012-09-20	Proyecto De Biomedicina Cima, S.L.	Immunogenic compositions and methods for their use
SG11201507883SA (en)	2013-03-29	2015-10-29	Sumitomo Dainippon Pharma Co Ltd	Wt1-antigen peptide conjugate vaccine
WO2014157704A1 (ja) *	2013-03-29	2014-10-02	大日本住友製薬株式会社	Ｅｒａｐ１によるトリミング機能をきっかけとしたコンジュゲートワクチン
US10272144B2 (en)	2013-07-31	2019-04-30	Bioventures, Llc	Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens
JP2017518958A (ja) *	2014-03-19	2017-07-13	マッカイメディカルファウンデイションザプレスビテリアンチャーチインタイワンマッカイメモリアルホスピタルＭａｃｋａｙＭｅｄｉｃａｌＦｏｕｎｄａｔｉｏｎＴｈｅＰｒｅｓｂｙｔｅｒｉａｎＣｈｕｒｃｈＩｎＴａｉｗａｎＭａｃｋａｙＭｅｍｏｒｉａｌＨｏｓｐｉｔａｌ	免疫原性グリコペプチドに対する抗体、それを含む組成物、及びそれらの使用
US12383608B2 (en)	2016-11-30	2025-08-12	Sumitomo Pharma Co., Ltd.	WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides
CN107141355B (zh) *	2017-05-31	2021-05-14	中国人民解放军第四军医大学	一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) *	2017-12-29	2019-07-09	复旦大学	基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
EP4149531A1 (de)	2020-05-11	2023-03-22	Ose Immunotherapeutics	Impfstoff gegen sars-cov virus
US20230134067A1 (en)	2020-07-22	2023-05-04	3H Bio. Co., Ltd.	A peptide used for immunotherapeutics
KR102261457B1 (ko) *	2020-07-22	2021-06-09	(주)쓰리에이치바이오	면역 치료제용 펩타이드
WO2022268916A2 (en)	2021-06-23	2022-12-29	Ose Immunotherapeutics	Pan-coronavirus peptide vaccine
CA3248183A1 (en)	2022-04-14	2023-10-19	The Hospital For Sick Children	PFCSP-BASED IMMUNOGENS AND ASSOCIATED COMPOSITION AND METHODS
WO2025093541A1 (en)	2023-10-31	2025-05-08	Ose Immunotherapeutics	Combination of interleukin 7 and tumour associated antigen vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9406652A (pt) *	1993-03-05	1996-09-10	Cytel Corp	Composição
DE69435171D1 (de) *	1993-09-14	2009-01-08	Pharmexa Inc	Pan dr-bindeproteinen zur erhöhung der immunantwort

1997
- 1997-01-23 PT PT97902074T patent/PT876398E/pt unknown
- 1997-01-23 AU AU15827/97A patent/AU1582797A/en not_active Abandoned
- 1997-01-23 ES ES97902074T patent/ES2177927T3/es not_active Expired - Lifetime
- 1997-01-23 CA CA2242878A patent/CA2242878C/en not_active Expired - Lifetime
- 1997-01-23 EP EP97902074A patent/EP0876398B1/de not_active Expired - Lifetime
- 1997-01-23 DE DE69714011T patent/DE69714011T2/de not_active Expired - Lifetime
- 1997-01-23 CN CN97193221A patent/CN1214051A/zh active Pending
- 1997-01-23 DK DK97902074T patent/DK0876398T3/da active
- 1997-01-23 AT AT97902074T patent/ATE220687T1/de active
- 1997-01-23 WO PCT/US1997/001041 patent/WO1997026784A1/en not_active Ceased
- 1997-01-23 JP JP52697997A patent/JP4063879B2/ja not_active Expired - Lifetime
- 1997-01-23 BR BR9710404A patent/BR9710404A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0876398T3 (da)	2002-08-12
CA2242878C (en)	2010-06-22
CN1214051A (zh)	1999-04-14
JP2000504328A (ja)	2000-04-11
JP4063879B2 (ja)	2008-03-19
PT876398E (pt)	2002-12-31
CA2242878A1 (en)	1997-07-31
AU1582797A (en)	1997-08-20
EP0876398B1 (de)	2002-07-17
DE69714011T2 (de)	2003-02-27
DE69714011D1 (de)	2002-08-22
ES2177927T3 (es)	2002-12-16
BR9710404A (pt)	1999-08-17
WO1997026784A1 (en)	1997-07-31
EP0876398A1 (de)	1998-11-11

Publication	Publication Date	Title
ATE220687T1 (de)	2002-08-15	Die erzeugung einer immunantwort gegen erwünschte determinanten
DE69929444D1 (de)	2006-04-06	Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
EP2269632A3 (de)	2012-10-24	Immunstimulatorische Zusammensetzungen und Verfahren zur Stimulation einer Immunreaktion
JO2305B1 (en)	2005-09-12	Gels extracted from wood
GR3035941T3 (en)	2001-08-31	Vaccine adjuvants
TR28445A (tr)	1996-07-04	Jeotermal akici maddelerden güc üretmek icin usul ve tertibat.
DK0662005T3 (da)	1999-02-22	Mikropartikelpræparater af biologisk nedbrydelige copolymerer
ATE397005T1 (de)	2008-06-15	Sialyl-lewisa und sialyl-lewisx epitope analoge
IS5329A (is)	1999-12-29	Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar
BG103141A (en)	1999-08-31	Composition of a malaria vaccine
SG167667A1 (en)	2011-01-28	Nucleic acid compositions for stimulating immune responses
TR199501702A2 (tr)	1997-03-21	Jeotermal akiskandan güc üretmek icin usul ve cihaz.
DE69839696D1 (de)	2008-08-21	Anellierte dihydropyrane
ATE404667T1 (de)	2008-08-15	Chromatin-regulatorgene
ATE464910T1 (de)	2010-05-15	Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
NO964238L (no)	1996-10-04	Halofantrin-fri-base for behandling av malaria og blandinger
DK0868491T3 (da)	2000-08-21	Voks-frit møbelpolermiddel med siliconebestanddele
GB2288183B (en)	1998-02-18	Composition and method of preparing microemulsion blends
NO20001421L (no)	2000-05-19	T-cellevaksinasjon for behandling av multippel sklerose
DK1146906T3 (da)	2011-10-24	Mukosalt afgivelsessystem
DK0786004T3 (da)	2001-10-22	Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
TR200001102T2 (tr)	2000-08-21	İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
CY1110718T1 (el)	2015-06-10	Ανοσογονες λιποσωμικες συνθεσεις
ES2192610T3 (es)	2003-10-16	Aminouracilos substituidos.
BG100248A (bg)	1996-07-31	Инхибитори на скваленсинтетаза